Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Themes | Quick Take |
|---|---|---|---|---|---|---|---|
Buyside Digest is not affiliated with, and does not endorse, The Sound Shore Fund. This analysis is provided for institutional research purposes only and is not investment advice.
"The Sound Shore Fund posted moderate Q2 gains, trailing benchmarks, but capitalized on volatility to buy discounted healthcare assets while benefiting from AI infrastructure tailwinds via FLEX."
In Q2 2025, the Sound Shore Fund Investor Class (SSHFX) and Institutional Class (SSHVX) advanced 3.06% and 3.10% respectively, trailing the Russell 1000 Value Index and S&P 500. Despite healthcare lagging due to regulatory uncertainty, the fund took advantage of market volatility to add to high-conviction holdings Teva Pharmaceutical and Hologic. FLEX was the fund's top performer, benefiting from increased data center demand. Conversely, AES was hampered by prospective tax credit changes but gained post-quarter on buyout rumors. Disney is viewed as an attractive risk/reward play with its upcoming ESPN streaming launch. The portfolio remains highly discounted at a forward P/E of 12 times.
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Market Conviction
High-conviction positioning: The Sound Shore Fund posted moderate Q2 gains, trailing benchmarks, but capitalized on volatility to buy discounted healthcare assets while benefiting from AI infrastructure tailwi...
Growth Outlook
Market outlook remains above average conviction: The Sound Shore Fund posted moderate Q2 gains, trailing benchmarks, but capitalized on volatility to buy discounted healthcare assets while benefiting from AI infrastructure tailwi...
Risk Appetite
Risk appetite posture is moderate conviction: The Sound Shore Fund posted moderate Q2 gains, trailing benchmarks, but capitalized on volatility to buy discounted healthcare assets while benefiting from AI infrastructure tailwi...
Capital Deployment
Manager actively deployed capital into high-conviction opportunities. The Sound Shore Fund posted moderate Q2 gains, trailing benchmarks, but capitalized on volatility to buy discounted healthcare assets while benefiting from AI infrastructure tailwi...
Forward Guidance
Forward guidance signal: The Sound Shore Fund posted moderate Q2 gains, trailing benchmarks, but capitalized on volatility to buy discounted healthcare assets while benefiting from AI infrastructure tailwi...
Language Signal
Tone analysis indicates above average conviction language: The Sound Shore Fund posted moderate Q2 gains, trailing benchmarks, but capitalized on volatility to buy discounted healthcare assets while benefiting from AI infrastructure tailwi...
Perceived Risk
Perceived risk level is evaluated as moderate conviction. The Sound Shore Fund posted moderate Q2 gains, trailing benchmarks, but capitalized on volatility to buy discounted healthcare assets while benefiting from AI infrastructure tailwi...
Opportunity Density
Opportunity density index indicates above average conviction actionable entry points. The Sound Shore Fund posted moderate Q2 gains, trailing benchmarks, but capitalized on volatility to buy discounted healthcare assets while benefiting from AI infrastructure tailwi...
Time Horizon
Investment time horizon reflects a high conviction orientation. The Sound Shore Fund posted moderate Q2 gains, trailing benchmarks, but capitalized on volatility to buy discounted healthcare assets while benefiting from AI infrastructure tailwi...
